The global influenza diagnostics market is anticipated to grow significantly during the forecast period due to the growing prevalence of influenza, increasing demand for faster diagnosis and control of influenza, and government initiatives in awareness and diagnostic programs, which are influencing the growth of the influenza diagnostics market globally.
The report titled “Influenza Diagnostics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall influenza diagnostics market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on test type and different geographical regions. The report also includes sections on the competitive profiling of the leading players in the global influenza diagnostics market, appealing investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.
Geographically, the global influenza diagnostics market is studied for the following regional markets:
- Rest of Europe
- Rest of Asia Pacific
- Rest of LATAM
Middle East and Africa
- North Africa
- rest of Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global influenza diagnostics market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global influenza diagnostics market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global influenza diagnostics market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global influenza diagnostics market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on test type, the global influenza diagnostics market is segmented as follows:
- Rapid Influenza Diagnostic Tests (RIDT)
- Cell Culture
Influenza is an acute respiratory disease caused by influenza type A, B, or C virus infection. It is preventable by vaccination or chemoprophylaxis and is treatable by specific antivirals. Influenza outbreaks and epidemics pose ongoing risks to global human public health. According to the World Health Organization (WHO), annually, 5–15% of the population globally is affected by upper respiratory tract infections due to influenza epidemics. Growing government initiatives to counter influenza are a prime factor that is driving the growth of the influenza diagnostics market worldwide. There are different types of diagnostic tests available in the market, such as rapid influenza diagnostic tests (RIDT), real-time reverse transcription polymerase chain reaction (RT-PCR), cell culture, the RSV test, rapid flu tests, serology, and immunofluorescence tests, which are performed according to the availability and reason for testing. It is studied that, currently, rapid influenza diagnostic tests (RIDT) hold the largest market share and are anticipated to grow during the forecast period due to their ease of use, rapid results, and accuracy. Moreover, WHO recommendations on the use of rapid testing for influenza diagnosis are further driving the growth of the rapid influenza diagnostic tests (RIDT) market globally. However, a high rate of false-negative results may negatively impact the growth of the market for rapid influenza diagnostic tests (RIDT).
For the purpose of this study, the global influenza diagnostics market is categorized into three segments:
- North America
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
The World Health Organization (WHO) reports that throughout the world, annual outbreaks result in 3–5 million severe cases and between 250,000 and 500,000 deaths due to influenza infection. Among the considered regional markets, North America, followed by Europe, is currently dominating the influenza diagnostics market globally due to a higher rate of in vitro diagnostics availability, technologically advanced medical devices, and the presence of key manufacturers, primarily driving the market growth in these regions. Initiatives by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), [J1], and the United States Food and Drug Administration (FDA) collaborated to characterize the virus, identify a candidate vaccine strain, and expedite manufacturing, fueling market growth in North America. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to rising healthcare awareness, a higher number of targeted populations, increasing demand for advanced diagnostic technologies, and government initiatives assisting the market growth during the forecast period in Asia Pacific.